Pseudomonas infection refers to a disease caused by one of the species of the genus Pseudomonas. P. aeruginosa is an opportunistic human pathogen, most commonly affecting immunocompromised patients, such as those with cystic fibrosis or AIDS. Infection can affect many different parts of the body, but infections typically target the respiratory tract (e.g. patients with CF or those on mechanical ventilation), causing bacterial pneumonia. In a surveillance study between 1986 and 1989, P. aeruginosa was the third leading cause of all nosocomial infections, and specifically the number one leading cause of hospital-acquired pneumonia and third leading cause of hospital-acquired UTI. Treatment of such infections can be difficult due to multiple antibiotic resistance, and in the United States, there was an increase in MDRPA (Multidrug-resistant Pseudomonas aeruginosa) resistant to ceftazidime, ciprofloxacin, and aminoglycosides, from 0.9% in 1994 to 5.6% in 2002.
MedImmune Ltd.
http://www.medimmune.com
|
MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.
Molecular engineering
Medicine
MedImmune LLC
https://www.astrazeneca.com
|
MedImmune develops medicines for unmet medical needs worldwide.
As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. Since its founding in 1988, MedImmune has remained committed to scientific innovation and medical progress, continually looking beyond standard expectations and pushing the boundaries of what is possible.
Medicine
Pharmacy and Therapeutics
Autoimmunity
Inflammation
Neuroscience
Oncology
Oncology drugs
Monoclonal antibody
Immunotherapy
Drug development
Drug discovery
Biopharmaceutical
Biotechnology
Cardiovascular agent
Genomics
Adalimumab
Cell therapy
Clinical trial
Biomedicine
Antibody-drug conjugate
Pherecydes Pharma SA
http://www.pherecydes-pharma.com
|
Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to its outer membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.
Phage therapy
Medical equipment
Antibiotic resistance
Bacteriophage
Biotechnology
Antibiotics
Fidaxomicin
Ceftaroline fosamil
Ceftolozane
Telavancin
Rifampicin
Oritavancin
Avibactam
Antibacterial Drug Resistance
Ceftazidime/avibactam
Dalbavancin
Imipenem
Cilastatin
CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.
Sugar
Food processing
Food industry
Amino acid
Adipose tissue
Feed additive
Methionine
Clinical trial
Pastry
Polyhydroxyalkanoates
Biodegradable plastic
Bioplastic
Fructooligosaccharide
Elymus repens
Corn oil
Biomedicine
Valine
Sunflower oil
Biotechnology
Vegetable oil
Revalesio Corp.
http://www.revalesio.com
|
Revalesio Corporation, a biotechnology company, develops therapeutics for the treatment of inflammatory diseases. It offers respiratory, cardiovascular, neuroscience, orthopedic, wound care, and oncology products. The company was formerly known as Microdiffusion, Inc. and changed its name to Revalesio Corporation in August 2007. Revalesio Corporation was founded in 2000 and is based in Tacoma, Washington.
Formoterol
Bronchodilator
Neuroscience
Alzheimer's disease
Oncology
Biotechnology
Drug development
Drug discovery
Armata Pharmaceuticals, Inc.
http://www.armatapharma.com
|
Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of drug-resistant bacterial infections.
Antibiotic overuse has led to the marked rise of multidrug-resistant bacteria, putting us on the verge of a post-antibiotic era in which common infections can be serious or life-threatening. Additionally, the use of broad-spectrum antibiotics is known for disrupting the ecology of the human microbiome, leading to disease.
The company was founded in 2005 and is based in Marina del Rey, CA, USA.
Biotechnology
Bacteriophage
Staphylococcus aureus
Phage therapy
Antibiotic resistance
Guanosine diphosphate
Antiviral drug
Infection drug
Microbiome
Coronavirus disease 2019 (COVID-19)
Biopharmaceutical
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.
Biopharmaceutical
TUMOR NECROSIS FACTOR BLOCKER
Medicine
Cancer chemotherapy
Molecular genetics
Rheumatoid arthritis
Autoimmune disease
Oncology drugs
Monoclonal antibody
Clinical trial
Immunotherapy
Bevacizumab
Cardiovascular agent
Adalimumab
Biosimilar
Genomics
Cancer immunotherapy
Antibody
Rituximab
Miles is a mobile app that automatically tracks and logs mileage for business purposes. Miles users can now create and export their mileage logs without the need of manual input.
Mobile app
Chemical engineering
Trinity Biosystems, Inc.
http://www.trinitybiosystems.com
|
Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA.
Medicine
Pharmacy and Therapeutics
Mucosal epithelium
Transport Pathway
Macromolecule
Therapeutic protein
Physiology
Payload
Universitätsklinikum Hamburg-Eppendorf
Universitätsklinikum Hamburg-Eppendorf operates as a university hospital. It offers basic and specialized healthcare services, and it offers medical students an opportunity to practice their profession. The hospital was founded on the 19th of May, 1889 and is located in Hamburg, Germany.
Retinitis
Cornea
Eye drop
BCG vaccine
HIV vaccine
Conjugate vaccine
Toxoid
DNA vaccination
Prosthesis
Retina
Blindness
Macular degeneration
Ophthalmology
Glaucoma
Optometry
Dementia
Molecular diagnostics
Biomedicine
Établissement Français du Sang
http://www.donneurs.efs.sante.fr
|
Établissement Français du Sang collects, prepares, qualifies and distributes blood transfusion products. The company is headquartered in Saint-Denis, France.
Blood transfusion
Blood product
Sumitomo Pharmaceuticals Co., Ltd.
http://www.sumitomopharm.com
|
Manufactures and sells pharmaceuticals
Ares Genetics GmbH
http://www.opgen.com/ares
|
OpGen uses molecular microbiology and bioinformatics to create diagnostic solutions that will improve the treatment of life-threatening, drug-resistant infections. By employing precision medicine to guide antibiotic therapy selection and aid enhance antibiotic stewardship, the business hopes to drastically revolutionize patient care.
Software
Biology
Artificial intelligence
Drug resistance
DNA sequencing
Exosome
Biomedicine
Biotechnology
Genetic engineering
Microbiome
Bioinformatics
Coronavirus disease 2019 (COVID-19)
Pharmaceutics
Aptamer
Drug design
Cancer research
Toxicology
Clinical research
Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.
Blood testing
Biology
Drug discovery
Biopharmaceutical
Biotechnology
Blood transfusion
Immunotoxin
Daclizumab
Nivolumab
Peramivir
Interleukin 2
Zanamivir
Oseltamivir
Vemurafenib
Paclitaxel
Sulfuric acid
Ipilimumab
Interleukin
Immunosuppressive drug
Antibody
CJ Corporation (Korean: 씨제이㈜) is a South Korean conglomerate holding company headquartered in Seoul. It comprises numerous businesses in various industries of food and food service, pharmaceutics and biotechnology, entertainment and media, home shopping and logistics. CJ Group was originally a branch of Samsung until it separated in the 1990s.
Biotechnology
Pharmaceutics
Biomedicine
Cell signaling
Exosome
Elymus repens
Silage
Valine
Yeast
Biosimilar
Animal nutrition
Social media
Seasoning
Amino acid
Herb
Spice
Generic drug
Gastrointestinal agent
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ.
Miles Laboratories, Inc., part of Bayer AG, is a company headquartered in Rexdale, ON, Canada, that manufactures pharmaceutical products.
GlaxoSmithKline Biologicals SA
Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever
Medicine
Rubella
Hepatitis
Typhoid fever
Quality control
Clinical trial
People also interested in
Chemical engineeringOphthalmologyNeuroscienceBiomedicineClinical trialExosomeBiodegradable plasticCell therapyCorn oilBlood testing